Category: China
-
Mediation and Arbitration as Settlement Pathways in Chinese Patent Disputes
China has no UPC Patent Mediation and Arbitration Centre equivalent. Its relevant pathways are more dispersed. This article maps those pathways and explains how they may matter in Chinese patent disputes.
-
OxFora’s 14th Intellectual Property and Competition Forum less than one week away (23, 24 June)
The 14th edition of this event will be held in the DPMA Forum, Munich next week. ip fray plans to cover the conference during and after it takes place.
-
Infineon disputes Innoscience’s claim of “final Chinese GaN patent victory”
In a statement to ip fray, Infineon said China’s Supreme People’s Court decision concerned preliminary injunction relief and that the main proceedings remain ongoing.
-
Chongqing court’s higher 5G aggregate royalty burden in ZTE v. Samsung ruling (than in OPPO v. Nokia) has reasons
In ZTE v. Samsung, the Chongqing court explained why the 5G aggregate royalty rate adopted in OPPO v. Nokia should not be treated as an industry-recognised benchmark and characterised it instead as an “interim figure” used to resolve a particular dispute.
-
German innovative strength has significantly weakened due to insufficient investment in R&D, report reveals
China has taken ownership of more than 11,300 patents developed in Germany over the past ​two decades, and that number is likely to keep increasing, according to a study by the ‌German Economic Institute (IW).
-
After the platform peak: Alibaba’s patent map points to the cloud-native AI buildout
Alibaba’s patent map is becoming less about the platform it built first, and more about the infrastructure it is positioning for AI-driven growth, cloud expansion, and the next layer of digital services.
-
Huawei announces new semiconductor law: shows independence from Western chip supply
The new principle, known as “the Tau (τ) Scaling Law”, has “proven” it can resolve global semiconductor and electronic system challenges, and Huawei “welcomes” peers in joining it in verifying the law, Huawei announced during the IEEE International Symposium on Circuits and Systems today.
-
China Implements Pharmaceutical Test Data Protection Rules: A New Era for Drug Data Protection
China has promulgated the Measures for the Implementation of Pharmaceutical Test Data Protection and the Work Scheme for Pharmaceutical Test Data Protection, which together operationalize for the first time a formal PTDP system in China, granting up to six years of data exclusivity to qualifying chemical and biological drug applicants.
-
Decoding BYD’s patent footprint: from stack control to scale, from foreign bets to policy friction
BYD used to look, from outside China, like a distant domestic EV champion. It no longer does. This study mines BYD’s patent-family data for the underlying strategy, not just the counts. The result is a map of stack control, foreign bets, and policy-constrained markets.
-
Chinese ZTE v. Samsung FRAND judgment: third way, but much closer to Munich than London; English machine translation and analysis
A redacted version of the full Chinese ZTE v. Samsung FRAND rate judgment has become available over the weekend. Here you can find an English machine translation and a Chinese author’s personal take.